Crinetics Pharmaceuticals
CRNX • NASDAQ
Crinetics Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO R. Scott Struthers, with a market cap of $4.1B.
Market Cap$4.1B
Employees210.0
CEOR. Scott Struthers
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Crinetics Pharmaceuticals FAQ
Common questions about Crinetics Pharmaceuticals
Crinetics Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $8.1M.
Crinetics Pharmaceuticals has approximately 210 employees.